Patents by Inventor Pejman Soroosh

Pejman Soroosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20230340155
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 26, 2023
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Suppression of Microglial Activation with Innate Lymphoid Cells
    Publication number: 20230285459
    Abstract: Compositions and methods of using ILC2 to reduce microglial activation or to reduce blood-brain barrier (BBB) permeability are described. Also described are methods and compositions that use an agent that increases the number of activated ILC2 to reduce microglial activation or BBB permeability.
    Type: Application
    Filed: April 27, 2023
    Publication date: September 14, 2023
    Inventors: German Rodrigo Aleman Muench, Homayon Banie, Anindya Bhattacharya, Noel Christopher Derecki, Pejman Soroosh
  • Antibodies that specifically bind PD-1 and methods of use
    Patent number: 11746161
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: September 5, 2023
    Assignee: Janssen Biotech, Inc.
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Antibodies that specifically bind PD-1 and methods of use
    Patent number: 10995149
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: May 4, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20210102000
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 8, 2021
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yevgeniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson
  • Suppression of Microglial Activation with Innate Lymphoid Cells
    Publication number: 20200016205
    Abstract: Compositions and methods of using ILC2 to reduce microglial activation or to reduce blood-brain barrier (BBB) permeability are described. Also described are methods and compositions that use an agent that increases the number of activated ILC2 to reduce microglial activation or BBB permeability.
    Type: Application
    Filed: June 25, 2019
    Publication date: January 16, 2020
    Inventors: German Rodrigo Aleman Muench, Anindya Bhattacharya, Noel Christopher Derecki, Pejman Soroosh
  • Antibodies that Specifically Bind PD-1 and Methods of Use
    Publication number: 20180355061
    Abstract: Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.
    Type: Application
    Filed: June 4, 2018
    Publication date: December 13, 2018
    Inventors: Qiang Chen, Suzanne Cole, Karen Duffy, Yanxia Guo, Debra Gardner, Damon Hamel, Shannon Hitchcock, Ann Lacombe, Jinquan Luo, Ravi Malaviya, Yavegniya Orlovsky, Pejman Soroosh, Melissa Swiecki, Deepti Wilkinson